PerkinElmer Signs $250M Digital Imaging Agreement With GE; Expands Long-Term Relationship Providing Amorphous Silicon Digital X-Ray Detectors.

Business Editors/High-Tech Writers

BOSTON--(BUSINESS WIRE)--Jan. 26, 2004

PerkinElmer, Inc. (NYSE: PKI) today announced the signing of a long-term, exclusive agreement with General Electric Corporation (NYSE: GE) to supply PerkinElmer's amorphous silicon digital flat panel X-Ray detector technology to GE Medical Systems (GEMS) and GE Aircraft Engines (GEAE). This agreement marks a major milestone in PerkinElmer's six-year relationship with GEMS, as the exclusive supplier of digital X-Ray detectors for advanced medical imaging and industrial applications. Under the agreement, PerkinElmer Optoelectronics will be sole provider of this technology to GEMS and GEAE for the next five years, a deal estimated to include more than $250 million of purchases by GE.

PerkinElmer's amorphous silicon X-Ray detectors provide detailed radiographic and fluoroscopic images of the human anatomy in digital form, offering physicians the highest sensitivity of detection and resolution during medical procedures. X-Ray signals are converted into digital images, providing exceptional image clarity with a large field of view for clinical applications that require exact precision, such as, radiography, cardiology and angiography procedures. As hospitals and clinics continue to switch from film-based to digital X-Ray, demand for GE's systems utilizing amorphous silicon detectors will continue to grow. This technology also is a key driver in opening up market opportunities in non-destructive testing, and has potential application in areas such as homeland security and biometric identification.

"Digital X-ray technology increases the ability to not only capture, store and retrieve images, but improve the diagnosis and treatment process for patients worldwide," said Joe Hogan, President and CEO of GEMS. "We look forward to building upon our strong industry-leading relationship with PerkinElmer as digital X-ray becomes the standard in healthcare."

"We are very pleased to continue our strong relationship with GE, and remain dedicated to providing the best digital imaging technology available today," said Greg Summe, Chairman and CEO, PerkinElmer, Inc. "GEMS sets the pace in imaging technology, enabling healthcare providers with the best tools available, to improve the quality of life worldwide."

PerkinElmer Optoelectronics became a supplier of digital medical X-Ray detectors to GEMS in 1997, and has delivered more than 1,500 detectors to GEMS. As hospitals continue to expand their digital capabilities, GEMS has expanded its biomedical and digital imaging technology portfolio to meet this growing demand.

Factors Affecting Future Performance

This press release contains "forward-looking" statements within the meaning of the Private Securities Litigation Reform Act of 1995. Any statements contained in this press release that relate to prospective events or developments, including, without limitation, statements regarding our estimate for 2003 results of operations, are deemed to be forward-looking statements. Words such as "believes," "anticipates," "plans," "expects," "projects," "forecasts," "will" and similar expressions are intended to identify forward-looking statements. There are a number of important factors that could cause actual results or events to differ materially from those indicated by these forward-looking statements, including risks related to our debt levels, our ability to comply with the financial covenants contained in our credit agreements, a further downturn in our customers' markets, our failure to introduce new products in a timely manner, regulatory changes, risks related to our international operations, our inability to integrate acquired businesses into our existing business and to successfully combine our Life and Analytical Sciences businesses and competition, as well as other factors which we describe under the caption "Forward-Looking Information and Factors Affecting Future Performance" in our most recently filed annual report on Form 10-K and in our most recently filed quarterly report on Form 10-Q. We disclaim any intention or obligation to update any forward-looking statements as a result of developments occurring after the date of this press release.

General Electric Company, headquartered in Fairfield, CT, is a diversified technology and services company dedicated to creating products that make life better from aircraft engines and power generation to financial services, medical imaging, television broadcasting and plastics. GE Company operates in more than 100 countries and employs more than 315,000 people worldwide, including approximately 75,000 in Europe.

GE Medical Systems is a global leader in medical imaging, healthcare services and information technology. Its offerings include networking and productivity tools, clinical information systems, patient monitoring systems, surgery and vascular imaging, conventional and digital X-Ray, computed tomography, electron beam computed tomography, magnetic resonance, ultrasound and bone mineral densitometry, positron emission tomography, nuclear medicine and a full line of clinical and business services. For more than 100 years, health-care providers worldwide have relied on GE Medical Systems for high quality medical technology and productivity solutions. GE Medical Systems operates in more than 100 countries and employs more than 30,000 people worldwide.

GE Aircraft Engines (GEAE), a division of General Electric Company (NYSE: GE), is the world's leading manufacturer of jet engines for civil and military aircraft, including engines produced by CFM International, a 50/50 joint company of Snecma Moteurs and GE. GEAE also manufactures gas turbines, derived from its highly successful jet engine programs, for marine and industrial applications. In addition, GEAE provides comprehensive maintenance support, through its GE Engine Services operation, for GE and non-GE jet engines in service throughout the world. Visit GEAE online at: http://www.geae.com.

PerkinElmer, Inc. is a global technology leader focused in the following businesses - Life and Analytical Sciences, Optoelectronics and Fluid Sciences. Combining operational excellence and technology expertise with an intimate understanding of our customers' needs, PerkinElmer provides products and services in health sciences and other advanced technology markets that require innovation, precision and reliability. The Company serves customers in more than 125 countries, and is a component of the S&P 500 Index. Additional information is available through www.perkinelmer.com or 1-877-PKI-NYSE.